In vitro activity of DQ-2556, a new cephalosporin | Zendy

Teruo Fujimoto | Zendy; Tatsuya Otani | Zendy; R Nakajima | Zendy; T Une | Zendy; Y Osada | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In vitro activity of DQ-2556, a new cephalosporin

Author(s) -

Teruo Fujimoto,

Tatsuya Otani,

R Nakajima,

T Une,

Y Osada

Publication year - 1986

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.30.4.611

Subject(s) - cefotaxime , ceftazidime , cephalosporin , microbiology and biotechnology , haemophilus influenzae , neisseria gonorrhoeae , antibacterial agent , pseudomonas aeruginosa , biology , antibiotics , bacteria , genetics

The in vitro antibacterial activity of DQ-2556, a new semisynthetic cephalosporin, was compared with that of ceftazidime and cefotaxime. The activity of DQ-2556 against members of the family Enterobacteriaceae was roughly comparable to that of cefotaxime. Against Pseudomonas aeruginosa, DQ-2556 was slightly less active than ceftazidime. DQ-2556 was more active than the reference cephalosporins against staphylococci. Haemophilus influenzae and Neisseria gonorrhoeae were also highly susceptible to DQ-2556.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research